Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 20FR12B Initial registration of securities (foreign private issuers)
- 2.1 EX-2.1
- 3.1 EX-3.1
- 4.1 EX-4.1
- 4.2 EX-4.2
- 4.3 EX-4.3
- 4.4 EX-4.4
- 4.5 EX-4.5
- 4.6 EX-4.6
- 4.7 EX-4.7
- 4.8 EX-4.8
- 4.9 EX-4.9
- 4.10 EX-4.10
- 4.11 EX-4.11
- 4.12 EX-4.12
- 4.13 EX-4.13
- 4.14 EX-4.14
- 4.15 EX-4.15
- 4.16 EX-4.16
- 4.17 EX-4.17
- 4.18 EX-4.18
- 4.19 EX-4.19
- 4.20 EX-4.20
- 4.21 EX-4.21
- 4.22 EX-4.22
- 4.23 EX-4.23
- 4.24 EX-4.24
- 4.25 EX-4.25
- 4.26 EX-4.26
- 4.27 EX-4.27
- 4.28 EX-4.28
- 4.29 EX-4.29
- 8.1 EX-8.1
- 15.1 EX-15.1
BLRX similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form 20-F of our report dated March 27, 2011, relating to the financial statements of BioLineRx Ltd., which appears in such Registration Statement. We also consent to the reference to us under the heading “Auditors” and in such Registration Statement.
/s/ Kesselman & Kesselman
Tel Aviv, Israel
July 1, 2011